National and international surgical scientific, educational, quality, and advocacy organization; 501(c)(3)
One uniform surface for comparison; detailed evidence is below.
The score summarizes assessed evidence; evidence coverage is reported separately.
Form 990 accounting categories reconcile exactly. Program services do not identify hospitals, surgeons, governments, program participants, or other customers; capital gains are not an operating payer class.
| Accounting category | Amount | Share |
|---|---|---|
| Program services | $101.39M | 57.13% |
| Net gain on asset sales | $42.68M | 24.05% |
| Contributions and grants | $24.97M | 14.07% |
| Investment income | $5.58M | 3.14% |
| Royalties | $1.03M | 0.58% |
| Rental income | $1.02M | 0.58% |
| Other revenue | $734,514 | 0.41% |
| Net inventory sales | $67,240 | 0.04% |
| Total | $177.47M | 100.00% |
Primary constituency: Surgeons, especially Fellows, with trainee and affiliate categories; the organization is not built to represent physicians broadly.
Physician alignment: Generally supportive for surgeons; role dependent for employed, independent, trainee, executive, and non-surgical physicians.
Funding model: Program-service led with substantial contributions, investment returns, and capital gains; ultimate payer concentration is indeterminate.
Primary influence: Board of Regents and Fellows/Governors formally; Executive Director and staff operationally; hospitals and program customers influence quality-program scale without a disclosed payer hierarchy.
The American College of Surgeons is a surgeon-governed scientific, educational, quality, and advocacy organization with approximately 95,000 members. Fellows and Governors connect the membership to a 24-member Board of Regents, while Executive Director and CEO Patricia Turner leads operations. FY2025 Form 990 revenue was $177.47 million, including $101.39 million in program-service revenue, $24.97 million in contributions and grants, and $42.68 million in asset-sale gains. These accounting categories do not reveal the ultimate payer mix, and the public record does not separate individual from employer- or institution-paid dues. The documented work on surgical quality, education, payment stability, prior authorization, workplace standards, and patient safety is strongly mission aligned. The B grade is generally favorable for evidence and accountability, with funding independence left not evaluable rather than guessed.
One sentence: ACS is a surgeon-governed organization with strong surgical quality and advocacy work, but public disclosures do not reveal the ultimate payer mix behind most operating revenue.
Every organization uses the same twelve evidence sections and order.
Documented fact: ACS describes itself as a scientific and educational organization of surgeons. It reports approximately 95,000 members worldwide, more than 50 million patient records tracked through surgical registries, and more than 2,500 hospital participants in quality programs.[1]
Mission: Improve surgical care and safeguard standards in an optimal and ethical practice environment. Its current strategic plan began in mid-2025 after input from Regents, Governors, past presidents, young Fellows, residents, committees, and staff.[1]
The formal center is surgeons and Fellows. Fellows must be licensed medical-school graduates elected by the Regents. Associate Fellows and Residents are physician categories; Affiliate membership is available to physicians and nonphysicians in healthcare; medical students may join. Honorary Fellows cannot vote or hold office.[2]
| Constituency dimension | Evidence-supported conclusion | Confidence |
|---|---|---|
| Formal constituency | Surgeons, especially Fellows; additional trainee and affiliate categories exist. | High |
| Paying constituency | Members, program customers, contributors, related entities, investment/capital activity, and other sources; ultimate payer classes are not fully disclosed. | Moderate / low by class |
| Operational constituency | Surgeons, surgical patients, hospital quality-program participants, educators, trainees, and advocacy stakeholders. | Moderate-high |
| Beneficiaries | Surgical patients, surgeons, institutions using quality programs, and communities reached by public-safety programs. | High on reach; moderate on outcomes |
Fellows elect selected officers and Governors at member meetings.
The Board of Governors elects 23; the ACS president is the 24th.
The CEO and executive staff under Board of Regents authority.
The Board of Regents formally directs ACS affairs.
| Leader | Current role | Authority / context | Public compensation context |
|---|---|---|---|
| Anton N. Sidawy, MD, MPH, FACS | President, 2025–2026 | Spokesperson and ex officio Regent; presidency is not the sole operational authority. | Current compensation not yet in the FY2025 filing. |
| Lena M. Napolitano, MD, FACS | Chair, Board of Regents | Elected October 17, 2025; presides over the board that controls ACS affairs. | FY2025 filing reflects prior board role, not current-chair period. |
| Patricia L. Turner, MD, MBA, FACS | Executive Director & CEO | Runs operations, attends Regents/Governors meetings, coordinates committees and major meetings. | $1,151,185 reportable compensation plus $299,707 other compensation in FY2025 filing.[6] |
| Paige A. Rodgers, CPA, MBA | Chief Financial Officer | Finance and facilities; appointed by and serves at the pleasure of the Board of Regents. | $660,957 plus $96,697 other compensation in FY2025 filing.[6] |
| Christian Shalgian | SVP, Advocacy and Health Policy | Operational advocacy leader; FEC lists him as SurgeonsPAC treasurer. | $484,787 plus $173,330 other compensation in FY2025 filing.[6][8] |
Current officers also include First Vice-President Anne C. Mosenthal, MD, FACS; Second Vice-President Edward M. Barksdale Jr., MD, FACS; Immediate Past-President Beth H. Sutton, MD, FACS; Secretary Sherry M. Wren, MD, FACS; and Treasurer Larry R. Kaiser, MD, FACS. Officers-elect include Timothy J. Eberlein, MD, FACS, as president-elect.[3]
Governance strength: Current leadership, board structure, and appointment authority are publicly identifiable. Limitation: public materials reviewed do not provide member turnout, voting participation, delegate demographics, or a systematic public record of how dissenting member positions affect final policy.
The IRS Form 990 was filed April 16, 2026 for the fiscal year ended June 2025. A federal single-audit PDF is indexed because the organization crossed the federal-expenditure threshold, but the full audit report was not inspected in this review; therefore the Form 990 is described as a filed tax return, not as an audited financial statement.[6]
Cause IQ, using tax-filing data, lists immediate general support of $19.63 million from ACSPA, $0.373 million from the ACS Foundation, and a $0.201 million research grant from American Cancer Society, plus three smaller grants. These immediate sources do not establish the ultimate payer mix behind ACSPA or Foundation funds.[7]
For 2026, U.S. Fellows are listed at $764 annually; Associate Fellows at $300; resident and medical-student dues are $0; affiliate categories range from $100 to $300. ACS states that surgeons hold a single, seamless membership in ACS and its 501(c)(6) affiliate, ACSPA; a small portion of dues receipts - described as 3% to 5% - is retained by ACSPA for legislative support. The reviewed schedule does not identify whether each payment was personally, group, or employer funded.[4][5]
Unknown: Current payer concentration is therefore indeterminate. Concentration cannot be inferred from the 57.1% program-service category because that category may contain many customer types and many individual customers.
Interpretation: Better payer-class disclosure would improve accountability even if it showed a diversified, mission-aligned mix. The present gap lowers confidence in financial transparency; it is not evidence of misconduct.
| Entity | Tax / legal role | Documented function | Key money-flow evidence |
|---|---|---|---|
| American College of Surgeons | 501(c)(3), EIN 36-2192800 | Education, standards, quality, research, member services, permitted advocacy. | FY2025 revenue $177.47m. |
| American College of Surgeons Professional Association (ACSPA) | 501(c)(6) affiliate | Broader legislative advocacy, member services, and political programming; created in 2001. | Cause IQ lists $19.632m general support to ACS in FY2025.[5][7] |
| ACS Foundation | Related philanthropic entity, established 2005 | Raises voluntary support for research, scholarships, fellowships, and philanthropic programs. | Cause IQ lists $0.373m general support to ACS in FY2025.[7][16] |
| SurgeonsPAC | Federal connected PAC, committee C00382424 | Voluntary political contributions and candidate/committee giving; connected organization is ACSPA. | 2025–2026 cycle through June 30, 2026: $529,125 receipts, $653,000 contributions to other committees, $0 independent expenditures.[8] |
Holds management and control, appoints CEO/CFO/treasurer/secretary, sets dues, and directs affairs.
Elect selected officers and Governors; Governors elect Regents and connect Fellows to the board.
CEO and division leaders implement operations, advocacy, quality, education, membership, and revenue strategy.
Broader advocacy and federal political giving under distinct legal structures.
Hospitals participate in quality programs; commercial partnerships include member benefits and licensing.
Cannot be established from reviewed public data; no outside entity is labeled controlling.
Documented examples include a long-running member liability-insurance benefit with The Doctors Company, an ACS-authorized Stop the Bleed licensing agreement with Lifesaving Technologies, and ACS/Pfizer humanitarian awards. The FY2025 filing also reports $1.028 million in royalty revenue. These facts establish relationships and possible incentives, but they do not prove improper influence or policy control.[17][18][19][6]
Federal Lobbying Disclosure Act records were independently summed: ACS and ACSPA reported approximately $940,000 combined lobbying expenses across 2025 and $550,000 through the second quarter of 2026. SurgeonsPAC reported no independent expenditures in the current cycle through June 30, 2026; its reported contributions were individual contributions, with no transfers from affiliated committees.[8][9]
| Stated commitment | Relevant action | Assessment | Confidence |
|---|---|---|---|
| Improve surgical care and standards | National registries, more than 2,500 participating hospitals, and a 2026 risk-adjusted emergency-general-surgery report. | Supported | High on activity; moderate on independent outcome attribution |
| Support an optimal and ethical practice environment | 2026 workplace standards addressing fatigue, call, staffing, census, scheduling, administrative burden, and compensation. | Supported | High on policy; moderate on adoption |
| Advocate for surgeons and patients | Medicare payment and prior-authorization advocacy; grassroots and lobbying infrastructure. | Supported | High |
| Serve the broad physician community | ACS is surgeon-centered and does not claim to govern or represent all physician specialties. | Not applicable / not demonstrated | High |
| Balance specialty payment interests | ACS opposed shifting Medicare reimbursement toward primary care at specialists’ expense. | Role-specific tension | High for stated position |
| Funding accountability | Current Form 990 and related-entity records are available; a current payer-class breakdown is not. | Partially supported | Moderate-high |
Mission-conflict status: None found at a material organization-wide level. The primary-care payment dispute is a physician-segment tension within a surgeon-centered mission, not proof that ACS contradicted its stated surgical constituency.
| Role | Label | Strongest support | Strongest contrary fact / limitation | Confidence |
|---|---|---|---|---|
| Individual surgeon | Supportive | Direct surgical advocacy, standards, education, quality, and member voice. | Ultimate payer mix and individual-member influence are incompletely disclosed. | High / moderate |
| Employed surgeon | Supportive / mixed | Workplace standards, payment, prior authorization, autonomy. | Guidance is not employer enforcement; institutional customer interests may differ. | Moderate-high |
| Independent surgeon | Supportive | Payment stability and administrative-burden advocacy. | Few outcomes stratified by ownership model. | Moderate |
| Physician executive / group leader | Supportive / mixed | Quality systems, standards, data, leadership resources. | Participation cost and workflow tradeoffs may fall differently on clinicians. | Moderate |
| Primary care physician | Potential conflict | Shared interest in reducing administrative burden and stabilizing physician payment. | ACS opposed a primary-care-favoring budget-neutral payment shift. | High on payment issue; low broadly |
| Rural/community surgeon | Supportive / mixed | Rural Surgery Collaborative and workforce priorities. | Limited segment-specific outcome and governance data. | Moderate |
| Academic surgeon | Supportive | Education, research, quality science, leadership, publication. | Academic versus community priority balance is not quantified. | Moderate-high |
| Trainee / early career | Supportive | No annual dues for residents/students and formal participation pathways. | Voting and policy outcomes by career stage not published. | Moderate-high |
| Non-surgical physicians broadly | Not demonstrated | Some shared health-policy and patient-care benefits. | They are not the primary formal constituency. | High |
| Issue | Affected segment | Label | Evidence basis | Confidence |
|---|---|---|---|---|
| Professional and clinical autonomy | Surgeons | Supportive | Workplace standards and opposition to restrictive payer policies. | High |
| Prior authorization | Surgeons and patients | Supportive | Support for electronic processing and denial/delay transparency. | High |
| Payment sustainability | Surgeons | Supportive | Medicare stabilization advocacy. | High |
| Payment allocation | Primary care versus specialists | Potential conflict | Opposition to increasing primary-care payment at specialists’ expense. | High |
| Administrative burden | Employed and independent surgeons | Supportive | Prior authorization and workplace framework. | High |
| Independent-practice viability | Independent surgeons | Supportive / mixed | Payment and burden advocacy; limited practice-model outcomes. | Moderate |
| Practice ownership and consolidation | Independent and employed surgeons | Unknown | Reviewed sources did not establish a comprehensive current position or outcome record. | Low |
| Education and training | Trainees and surgeons | Supportive | Core organizational function and no annual trainee dues. | High |
| Scope and credentialing | Surgeons; nonphysician clinicians | Supportive for surgeons / potential conflict for expansion advocates | ACS supports surgical procedures being performed by appropriately trained surgeons. | High |
| Patient care and public health | Patients and communities | Supportive | Quality programs, Stop the Bleed, standards, and registries. | Moderate-high |
No recent material finding identified A scoped search of official federal enforcement, filing, and case-law sources did not identify a recent final government enforcement action against the parent ACS. This is a bounded search result, not proof that no matter exists in every jurisdiction.
| Matter | Parties / role | Status and outcome | Relevance |
|---|---|---|---|
| Koefoot v. American College of Surgeons, No. 81 C 4333 (N.D. Ill.) | Physicians and hospital board challenged ACS and individuals over antitrust and membership-rights issues tied to disciplinary/standards activity. | A jury returned a defense verdict on the antitrust segment in 1987; the 1988 opinion addressed membership claims and entered judgment for defendants. | Historical evidence that ACS standard-setting authority was legally challenged; the cited outcome was favorable to ACS.[20] |
| Duby v. American College of Surgeons, 468 F.2d 364 (7th Cir. 1972) | Member challenged disciplinary action. | Appellate court affirmed; historical case described adequate process. | Historical governance and disciplinary due-process context.[21] |
| Kamelgard v. American College of Surgeons, No. 1-08-0342 (Ill. App. Ct. 2008) | Physician sought pre-suit discovery concerning identities involved in an ACS review. | Appellate court reversed dismissal and remanded the discovery petition; not a final misconduct finding against ACS. | Shows disputes can arise over peer-review transparency; should not be presented as an adjudicated ethics violation.[22] |
| FY2025 Form 990 disclosures | ACS tax filing | Public summary flags first-class/charter travel and transactions reported on conflict-of-interest schedules. | These are disclosure flags requiring Schedule J/L context; they are not treated here as misconduct findings.[6] |
ACS publicly links a conflict-of-interest policy covering officers, officers-elect, Regents, selected Governors, the JACS editor-in-chief, and affiliated organizations.[3]
Confidence: Moderate. The review included current federal filings and targeted case/enforcement searches but was not a 50-state docket search or privileged legal audit.
Official bylaws, leadership pages, IRS-derived filings, FEC records, LDA filings, court opinions, and current policy documents were prioritized.
Accounting categories were reconciled to the Form 990 total but were not treated as payer identities.
ACS, ACSPA, Foundation, and SurgeonsPAC were kept separate; transfers were not double counted.
Supportive, mixed, potential conflict, not demonstrated, and unknown labels were assigned by role and issue - not derived from the overall grade.
Allegations, petitions, verdicts, and final decisions were described separately; no accusation was converted into a finding.
Funding independence/concentration was NE. The overall 80 was normalized from 68 earned points across 85 adequately supported points.
| Dimension | Score | Conclusion | Important unknown |
|---|---|---|---|
| Financial transparency and source identification | 10/15 · C | Current filing and categories are available; payer classes are not. | Customer and dues-payer mix. |
| Funding independence and concentration risk | NE | Insufficient evidence to quantify ultimate payer concentration. | Top-one/top-three payer concentration. |
| Mission-to-action alignment | 18/20 · A | Substantial current evidence of aligned quality, education, and advocacy work. | Independent outcome attribution across all programs. |
| Physician/member governance and representation | 13/15 · B | Surgeon-led and formally connected to Fellows through Governors. | Turnout, participation, and dissent-to-policy pathway. |
| Breadth across physician segments | 7/10 · C | Broad across surgical fields and career stages; not broad physician representation. | Results by practice model and demographic segment. |
| Leadership, conflict management, accountability | 8/10 · B | Current leadership, authority, compensation, and conflict policy are visible. | Schedule-level conflict detail and implementation outcomes. |
| Legal, regulatory, ethical record | 8/10 · B | No recent material federal enforcement finding identified; historical litigation largely favorable or non-final. | Comprehensive state/local docket coverage. |
| Outcomes and public accountability | 4/5 · B | Large registries and public program reporting; selected risk-adjusted outputs. | Independent, segment-specific outcome and burden measures. |
Likely effect: A diversified payer schedule and effective conflict safeguards would raise confidence and could improve the financial dimensions. A highly concentrated payer class with weak safeguards could lower them. Neither result should be presumed.
Publication status: Public review. A last-link check and final editorial approval are required before each release.
Organization review: The reviewed organization did not approve, edit, or veto the score. A factual correction process is described on the Blair Compass methodology and corrections pages.
Scope: Verification is limited to publicly accessible records. Private contracts, nonpublic minutes, sealed proceedings, and undisclosed conflicts are outside the available evidence.
Source rule: Primary and official records were preferred. Accounting categories were not converted into payer identities. Related entities were kept separate. Allegations were not treated as findings.
Verification: current leaders and major financial arithmetic were checked for this publication batch. Material corrections and future updates follow the published verification process.
